<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(11)</volume><submitter>Gallelli L</submitter><pubmed_abstract>Vitamin D might play a role in counteracting COVID-19, albeit strong evidence is still lacking in the literature. The present multicenter real-practice study aimed to evaluate the differences of 25(OH)D3 serum levels in adults tested for SARS-CoV-2 (acute COVID-19 patients, subjects healed from COVID-19, and non-infected ones) recruited over a 6-month period (March-September 2021). In a sample of 117 subjects, a statistically significant difference was found, with acute COVID-19 patients demonstrating the lowest levels of serum 25(OH)D3 (9.63 ± 8.70 ng/mL), significantly lower than values reported by no-COVID-19 patients (15.96 ± 5.99 ng/mL, p = 0.0091) and healed COVID-19 patients (11.52 ± 4.90 ng/mL, p > 0.05). Male gender across the three groups displayed unfluctuating 25(OH)D3 levels, </pubmed_abstract><journal>Nutrients</journal><pagination>3932</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8625490</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study.</pubmed_title><pmcid>PMC8625490</pmcid><pubmed_authors>Gallelli L</pubmed_authors><pubmed_authors>Muraca L</pubmed_authors><pubmed_authors>Gangemi P</pubmed_authors><pubmed_authors>Mancuso E</pubmed_authors><pubmed_authors>Mannino GC</pubmed_authors><pubmed_authors>De Sarro G</pubmed_authors><pubmed_authors>Monea G</pubmed_authors><pubmed_authors>Minchella P</pubmed_authors><pubmed_authors>G Amp P Working Group</pubmed_authors><pubmed_authors>Luciani F</pubmed_authors><pubmed_authors>Ammendolia A</pubmed_authors><pubmed_authors>Longhini F</pubmed_authors><pubmed_authors>de Sire A</pubmed_authors><pubmed_authors>Cosco L</pubmed_authors><pubmed_authors>Averta C</pubmed_authors><pubmed_authors>Andreozzi F</pubmed_authors><pubmed_authors>Colosimo M</pubmed_authors><pubmed_authors>Cione E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study.</name><description>Vitamin D might play a role in counteracting COVID-19, albeit strong evidence is still lacking in the literature. The present multicenter real-practice study aimed to evaluate the differences of 25(OH)D3 serum levels in adults tested for SARS-CoV-2 (acute COVID-19 patients, subjects healed from COVID-19, and non-infected ones) recruited over a 6-month period (March-September 2021). In a sample of 117 subjects, a statistically significant difference was found, with acute COVID-19 patients demonstrating the lowest levels of serum 25(OH)D3 (9.63 ± 8.70 ng/mL), significantly lower than values reported by no-COVID-19 patients (15.96 ± 5.99 ng/mL, p = 0.0091) and healed COVID-19 patients (11.52 ± 4.90 ng/mL, p > 0.05). Male gender across the three groups displayed unfluctuating 25(OH)D3 levels, </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-26T05:24:36.957Z</modification><creation>2022-02-11T13:34:42.543Z</creation></dates><accession>S-EPMC8625490</accession><cross_references><pubmed>34836187</pubmed><doi>10.3390/nu13113932</doi></cross_references></HashMap>